BioStem Technologies, Inc. (BSEM) vs Harvard Bioscience, Inc. (HBIO)
A side-by-side comparison of BioStem Technologies, Inc. and Harvard Bioscience, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BSEM
BioStem Technologies, Inc.
$2.57HealthcareDelayed quote: Oct 6, 2026, 10:29 AM EDT
HBIO
Harvard Bioscience, Inc.
$8.54HealthcareDelayed quote: Oct 6, 2026, 10:25 AM EDT
Total return — BSEM vs HBIO
growth of $100 · dividends reinvested · last 10yBSEM -72.4% (-12.1%/yr)HBIO -69.0% (-11.0%/yr)HBIO compounded faster over this window
BSEM HBIO
BSEM vs HBIO: by the numbers
- •BSEM is the larger company ($44M vs $39M market cap).
- •Both run net losses; HBIO's is the smaller (-11.86% vs -13.86% net margin).
Metrics side by side
Valuation
| Metric | BSEM | HBIO |
|---|---|---|
| P/S ratio | N/A | 0.44 |
| P/B ratio | 1.58 | 5.19 |
| EV / EBITDA | N/A | 10.53 |
Profitability
| Metric | BSEM | HBIO |
|---|---|---|
| Gross margin | 93.13% | 58.16% |
| Operating margin | -1.45% | 1.17% |
| Net margin | -13.86% | -11.86% |
| ROE | -102.45% | -140.36% |
| ROIC | -80.92% | 1.99% |
Growth (annualized)
| Metric | BSEM | HBIO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -4.62% |
| Total return CAGR (5Y) | 15.72% | -34.33% |
Frequently asked
- How have BSEM and HBIO total returns compared?
- Over the past 10 years, BSEM delivered -12.08% and HBIO delivered -11.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.